Predictors of acute gastrointestinal toxicity during pelvic chemoradiotherapy in patients with rectal cancer

Gastrointestinal Cancer Research

Volumn 6, Issue 5-6, 2013, Pages 129-136

  Yang, T Jonathan ^a   Oh, Jung Hun ^b   Son, Christina H ^a   Apte, Aditya ^b   Deasy, Joseph O ^b   Wu, Abraham ^a   Goodman, Karyn A ^a  

^a Department of Radiation Oncology ^*  (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAPECITABINE; FLUOROURACIL; FOLINIC ACID; OXALIPLATIN;

ADULT; AGE; AGED; ARTICLE; CHEMORADIOTHERAPY; COMPUTER ASSISTED RADIOTHERAPY; CONTINUOUS INFUSION; DIARRHEA; FEMALE; GASTROINTESTINAL TOXICITY; GENDER; HUMAN; INTENSITY MODULATED RADIATION THERAPY; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; PELVIC CHEMORADIOTHERAPY; PELVIS; PROCTITIS; RECTUM CANCER;

EID: 84891641155     PISSN: 19347820     EISSN: 19347987     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Stockholm Rectal Cancer Study Group: Preop-erative short-term radiation therapy in operable rectal carcinoma: a prospective randomized trial. Cancer 66:49-55, 1990
2. Cedermark B, Johansson H, Rutqvist LE, et al: The Stockholm I trial of preoperative short term radiotherapy in operable rectal carcinoma: a prospective randomized trial. Stockholm Colo-rectal Cancer Study Group. Cancer 75:2269-2275, 1995
3. Medical Research Council Rectal Cancer Working Party: Randomised trial of surgery alone versus radiotherapy followed by surgery for potentially operable locally advanced rectal cancer. Lancet 348:1605-1610, 1996
4. Swedish Rectal Cancer Trial: Improved survival with preoperative radiotherapy in resectable rectal cancer. N Engl J Med 336:980-987, 1997
5. Sauer R, Becker H, Hohenberger W, et al: Pre-operative versus postoperative chemoradio-therapy for rectal cancer. N Engl J Med 351: 1731-1740, 2004
6. Roh MS, Colangelo LH, O'Connell MJ, et al: Preoperative multimodality therapy improves disease-free survival in patients with carcinoma of the rectum: NSABP R-03. J Clin Oncol 27: 5124-5130, 2009
7. Bosset JF, Collette L, Calais G, et al: Chemotherapy with preoperative radiotherapy in rectal cancer. N Engl J Med 355:1114-1123, 2006
8. Smalley SR, Benedetti JK, Williamson SK, et al: Phase III trial of fluorouracil-based chemotherapy regimens plus radiotherapy in postoperative adjuvant rectal cancer: GI INT 0144. J Clin Oncol 24:3542-3547, 2006
9. Robertson JM, Lockman D, Yan D, et al: The dose-volume relationship of small bowel irradiation and acute grade 3 diarrhea during chemo-radiotherapy for rectal cancer. Int J Radiat Oncol Biol Phys 70:413-418, 2008
10. Robertson JM, Sohn M, Yan D: Predicting grade 3 acute diarrhea during radiation therapy for rectal cancer using a cutoff-dose logistic regression normal tissue complication probability model. Int J Radiat Oncol Biol Phys 77:66-72, 2010
11. Gunnlaugsson A, Kjellen E, Nilsson P, et al: Dose-volume relationships between enteritis and irradiated bowel volumes during 5-fluorou-racil and oxaliplatin based chemoradiotherapy in locally advanced rectal cancer. Acta Oncol 46:937-944, 2007
12. Chen RC, Mamon HJ, Ancukiewicz M, et al: Dose-volume effects on patient-reported acute gastrointestinal symptoms during chemoradia-tion therapy for rectal cancer. Int J Radiat Oncol Biol Phys 83:e513-e517, 2012
13. Samuelian JM, Callister MD, Ashman JB, et al: Reduced acute bowel toxicity in patients treated with intensity-modulated radiotherapy for rectal cancer. Int J Radiat Oncol Biol Phys 82:1981-1987, 2012
14. Garofalo M, Moughan J, Hong T, et al: RTOG 0822: a phase H study of preoperative (PREOP) chemoradiotherapy (CRT) utilizing IMRT in combination with capecitabine (C) and oxalipla-tin (O) for patients with locally advanced rectal cancer. Int J Radiat Oncol Biol Phys 81:S3-S4, 2011
15. Myerson RJ, Garofalo MC, El Naqa I, et al: Elective clinical target volumes for conformal therapy in anorectal cancer: a radiation therapy oncology group consensus panel contouring atlas. Int J Radiat Oncol Biol Phys 74:824-830, 2009
16. Baglan KL, Frazier RC, Yan D, et al: The dose-volume relationship of acute small bowel toxicity from concurrent 5-FU-based chemotherapy and radiation therapy for rectal cancer. Int J Radiat Oncol Biol Phys 52:176-183, 2002
17. Tho LM, Glegg M, Paterson J, et al: Acute small bowel toxicity and preoperative chemoradio-therapy for rectal cancer: investigating dose-volume relationships and role for inverse planning. Int J Radiat Oncol Biol Phys 66:505-513, 2006
18. Arbea L, Ramos LI, Martinez-Monge R, et al: Intensity-modulated radiation therapy (IMRT) vs. 3D conformal radiotherapy (3DCRT) in locally advanced rectal cancer (LARC): dosimetric comparison and clinical implications. Radiat Oncol 5:17, 2010
19. Simpson DR, Song WY, Moiseenko V, et al: Normal tissue complication probability analysis of acute gastrointestinal toxicity in cervical cancer patients undergoing intensity modulated radiation therapy and concurrent cisplatin. Int J Radiat Oncol Biol Phys 83:e81-e86, 2012
20. Roeske JC, Bonta D, Mell LK, et al: A dosimetric analysis of acute gastrointestinal toxicity in women receiving intensity-modulated whole-pelvic radiation therapy. Radiother Oncol 69: 201-207, 2003
21. Devisetty K, Mell LK, Salama JK, et al: A multi-institutional acute gastrointestinal toxicity analysis of anal cancer patients treated with concurrent intensity-modulated radiation therapy (IMRT) and chemotherapy. Radiother Oncol 93:298-301, 2009
22. Kavanagh BD, Pan CC, Dawson LA, et al: Radiation dose-volume effects in the stomach and small bowel. Int J Radiat Oncol Biol Phys 76: S101-S107, 2010
23. Huang EY, Sung CC, Ko SF, et al: The different volume effects of small-bowel toxicity during pelvic irradiation between gynecologic patients with and without abdominal surgery: a prospective study with computed tomography-based do-simetry. Int J Radiat Oncol Biol Phys 69:732-739, 2007
24. Chan LW, Xia P, Gottschalk AR, et al: Proposed rectal dose constraints for patients undergoing definitive whole pelvic radiotherapy for clinically localized prostate cancer. Int J Radiat Oncol Biol Phys 72:69-77, 2008
25. Swanson GP, Stathakis S: Rectal dose constraints for intensity modulated radiation therapy of the prostate. Am J Clin Oncol 34:188-195, 2011
26. Flores LT, Bennett AV, Law EB, et al: Patient-reported outcomes vs. clinician symptom reporting during chemoradiation for rectal cancer. Gastrointest Cancer Res 5:119-124, 2012